Use of flow cytometry in the phenotypic diagnosis of hodgkin's lymphoma
- 22 October 2018
- journal article
- review article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 96 (2) , 116-127
Abstract
Hodgkin's lymphoma (HL) has a unique immunophenotype derived from immunohistochemistry (positive for CD15, CD30, and Pax‐5; negative for CD3, CD20 in most cases, and CD45). The knowledge gained over recent years enables better diagnosis, prognosis, and treatment of HL. Flow cytometry as a tool for the diagnosis of classic HL has not been useful in the past due to the difficulty in isolating Reed–Sternberg cells as they are admixed in a rich inflammatory background which consists mainly of T cells, B cells, eosinophils, histiocytes, and plasma cells. However, in the recent past, several studies have tried to identify Reed–Sternberg cells using flow cytometry on fine needle aspiration or tissue biopsy of lymph nodes to confirm or supplement immunohistochemistry staining in diagnosis. Newer and more sensitive tools such as flow cytometry can be used for diagnosis, technology that may have been difficult in the past for diagnosis of this lymphoma subtype. Using flow cytometry, diagnosis is faster and could lead to point‐of‐care technology especially where we have typical immunophenotype signatures. © 2018 International Clinical Cytometry SocietyKeywords
This publication has 108 references indexed in Scilit:
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsBlood, 2011
- BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology GroupBlood, 2011
- Flow Cytometric Detection of the Classical Hodgkin Lymphoma: Clinical and Research ApplicationsAdvances in Hematology, 2010
- TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphomaJournal of Experimental Medicine, 2009
- CD20+ T-cell LymphomaAmerican Journal of Surgical Pathology, 2008
- Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDSBlood, 2006
- Inhibitors of NF-κB signaling: 785 and countingOncogene, 2006
- Good cop, bad cop: the different faces of NF-κBCell Death & Differentiation, 2006
- Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarraysLaboratory Investigation, 2006
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975